La '''mitoxantrone''' est une <span></span>dione produite par . Son noyau  hydroxy en fait une molécule apparentée aux s.
Le mitoxantrone est un agent antinéoplastique utilisé dans le traitement de certains types de , principalement le  métastasique, la leucémie myéloïde aigüe, et le .
Le mitoxantrone est un  de la  de type II. Il interrompt la synthèse et la réparation de l'ADN aussi bien chez les cellules saines que chez les cellules cancéreuses.
<br>Elle agit via son effet e.
Son principal intérêt par rapport aux anthracyclines est sa moindre cardiotoxicité.
<!--
Mitoxantrone is also used to treat multiple sclerosis (MS), most notably the subset known as secondary progressive MS. Mitoxantrone will not cure multiple sclerosis, but is effective in slowing the progression of secondary progressive MS and extending the time between relapses in relapsing-remitting MS and progressive relapsing MS.[1]
Side effects
As other drugs in its class, mitoxantrone may cause several adverse reactions of varying severity, such as nausea, vomiting, hair loss, heart damage, and immunosuppression. Some side effects may have delayed onset. Cardiomyopathy is a particularly concerning effect as it is irreversible; regular monitoring with echocardiograms or MUGA scans are recommended for people taking mitoxantrone.
The medication carries a total lifetime dose based on body surface area.[1]
-->